A detailed history of Primecap Management CO transactions in Thermo Fisher Scientific Inc. stock. As of the latest transaction made, Primecap Management CO holds 2,757,557 shares of TMO stock, worth $1.57 Billion. This represents 1.22% of its overall portfolio holdings.

Number of Shares
2,757,557
Previous 3,002,872 8.17%
Holding current value
$1.57 Billion
Previous $1.59 Billion 0.55%
% of portfolio
1.22%
Previous 1.28%

Shares

27 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2024

May 13, 2024

SELL
$528.82 - $599.43 $130 Million - $147 Million
-245,315 Reduced 8.17%
2,757,557 $1.6 Billion
Q4 2023

Feb 09, 2024

SELL
$431.41 - $532.94 $9.97 Million - $12.3 Million
-23,120 Reduced 0.76%
3,002,872 $1.59 Billion
Q3 2023

Nov 13, 2023

SELL
$498.29 - $574.41 $26 Million - $29.9 Million
-52,115 Reduced 1.69%
3,025,992 $1.53 Billion
Q2 2023

Aug 11, 2023

SELL
$508.46 - $591.13 $247 Million - $287 Million
-486,002 Reduced 13.64%
3,078,107 $1.61 Billion
Q1 2023

May 15, 2023

SELL
$535.0 - $604.82 $50.5 Million - $57.1 Million
-94,465 Reduced 2.58%
3,564,109 $2.05 Billion
Q4 2022

Feb 13, 2023

SELL
$484.71 - $571.37 $67.1 Million - $79.1 Million
-138,483 Reduced 3.65%
3,658,574 $2.02 Billion
Q3 2022

Nov 14, 2022

SELL
$507.19 - $604.49 $28.1 Million - $33.5 Million
-55,395 Reduced 1.44%
3,797,057 $1.93 Billion
Q2 2022

Aug 11, 2022

SELL
$500.9 - $612.21 $42.6 Million - $52.1 Million
-85,055 Reduced 2.16%
3,852,452 $2.09 Billion
Q1 2022

May 11, 2022

SELL
$524.0 - $644.92 $87.8 Million - $108 Million
-167,595 Reduced 4.08%
3,937,507 $2.33 Billion
Q4 2021

Feb 11, 2022

SELL
$569.0 - $667.24 $112 Million - $131 Million
-196,360 Reduced 4.56%
4,105,102 $2.74 Billion
Q3 2021

Nov 12, 2021

SELL
$509.53 - $609.78 $38.6 Million - $46.2 Million
-75,802 Reduced 1.73%
4,301,462 $2.46 Billion
Q2 2021

Aug 10, 2021

SELL
$441.0 - $508.24 $48.5 Million - $55.9 Million
-109,910 Reduced 2.45%
4,377,264 $2.21 Billion
Q1 2021

May 14, 2021

BUY
$439.85 - $518.83 $18.3 Million - $21.6 Million
41,649 Added 0.94%
4,487,174 $2.05 Billion
Q4 2020

Feb 08, 2021

SELL
$435.06 - $527.66 $66.4 Million - $80.6 Million
-152,716 Reduced 3.32%
4,445,525 $2.07 Billion
Q3 2020

Nov 13, 2020

SELL
$359.77 - $441.52 $51.2 Million - $62.8 Million
-142,200 Reduced 3.0%
4,598,241 $2.03 Billion
Q2 2020

Aug 13, 2020

SELL
$275.2 - $362.34 $28.9 Million - $38 Million
-104,910 Reduced 2.17%
4,740,441 $1.72 Billion
Q1 2020

May 14, 2020

BUY
$255.3 - $340.05 $23.7 Million - $31.6 Million
92,885 Added 1.95%
4,845,351 $1.37 Billion
Q4 2019

Feb 14, 2020

SELL
$271.93 - $328.04 $2.27 Million - $2.74 Million
-8,340 Reduced 0.18%
4,752,466 $1.54 Billion
Q3 2019

Nov 13, 2019

SELL
$268.46 - $305.43 $56.2 Million - $63.9 Million
-209,350 Reduced 4.21%
4,760,806 $1.39 Billion
Q2 2019

Aug 14, 2019

SELL
$257.51 - $295.55 $12 Million - $13.8 Million
-46,680 Reduced 0.93%
4,970,156 $1.46 Billion
Q1 2019

May 14, 2019

SELL
$212.17 - $273.72 $872,018 - $1.12 Million
-4,110 Reduced 0.08%
5,016,836 $1.37 Billion
Q4 2018

Feb 12, 2019

BUY
$208.47 - $251.98 $327,714 - $396,112
1,572 Added 0.03%
5,020,946 $1.12 Billion
Q3 2018

Nov 13, 2018

SELL
$205.57 - $244.32 $14.1 Million - $16.7 Million
-68,380 Reduced 1.34%
5,019,374 $1.23 Billion
Q2 2018

Aug 13, 2018

SELL
$203.14 - $219.53 $3.95 Million - $4.27 Million
-19,430 Reduced 0.38%
5,087,754 $1.05 Billion
Q1 2018

May 14, 2018

SELL
$192.98 - $224.11 $7.15 Million - $8.31 Million
-37,060 Reduced 0.72%
5,107,184 $1.05 Billion
Q4 2017

Feb 13, 2018

SELL
$182.03 - $200.37 $10.2 Million - $11.2 Million
-56,036 Reduced 1.08%
5,144,244 $977 Million
Q3 2017

Nov 13, 2017

BUY
$171.74 - $194.04 $893 Million - $1.01 Billion
5,200,280
5,200,280 $984 Million

Others Institutions Holding TMO

About THERMO FISHER SCIENTIFIC INC.


  • Ticker TMO
  • Exchange NYSE
  • Sector Healthcare
  • Industry Diagnostics & Research
  • Shares Outstandng 391,788,992
  • Market Cap $223B
  • Description
  • Thermo Fisher Scientific Inc. offers life sciences solutions, analytical instruments, specialty diagnostics, and laboratory products and service worldwide. The company's Life Sciences Solutions segment offers reagents, instruments, and consumables for biological and medical research, discovery, and production of drugs and vaccines, as well as di...
More about TMO
Track This Portfolio

Track Primecap Management CO Portfolio

Follow Primecap Management CO and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Primecap Management CO, based on Form 13F filings with the SEC.

News

Stay updated on Primecap Management CO with notifications on news.